Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RFX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KPNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIMAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BIN3-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ASH1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARPBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCY10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPA1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAFA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP162 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927526 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on